TOP 100 MEDICAL SITES
| |||
|
| |||
| |||
|
| |||
| GE Healthcare unveils cutting-edge MRI GE Healthcare has unveiled a new magnetic resonance imaging technology designed for obese and claustrophobic patients. feeds.bizjournals.com |
BioReference Laboratories, Inc to Speak at the UBS Global Life Sciences Conference (Business Wire) ELMWOOD PARK, N.J.----BioReference Laboratories, Inc announced today that Marc D. Grodman M.D., President and Chief Executive Officer, is scheduled to speak at the 2009 UBS Global Life Sciences Conference on Monday, September 21, 2009, at The Grand Hyatt Hotel located in New York, NY. us.rd.yahoo.com |
Respirators, Masks Work Equally Well Jeremy Singer-Vine summarizes research on flu protection, hormone replacement, lung cancer, and more. online.barrons.com |
Clarient to Present at Upcoming Healthcare Investor Conferences in New York City (PR Newswire) Clarient, Inc. , a premier technology and services resource for pathologists, oncologists and the pharmaceutical industry, today announced that it is scheduled to make presentations at two upcoming investor conferences in New York City. us.rd.yahoo.com |
Sunesis Pharma's Impressive Gain: Hoping for a Dip VFC submits: Shares of Sunesis Pharmaceuticals, Inc. (SNSS) rallied Thursday on an impressive run that saw the stock reach an intra-day high of $1.84, a full 131% price increase from the open. Earlier in the week, SNSS moved higher on news that the company's lead drug Voreloxin had proved a success in a recently completed Phase II trial that measured its effectiveness in the treatment of Acute Myeloid Leukemia [AML]. However, Thursday's big run has led to speculation that additional news may be pending; maybe partnership news.Complete Story » seekingalpha.com |